Ativos Alterar Data
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Biogen USD 32.09B 2.6B 2026-06
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.92B 651.07M 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Mesoblast USD 782.31M 2.38M 2025-12